The key to understanding the pathology of age-related retinal degenerations and Stargardt´s disease is understanding the protective role of the melanosome in RPE cells.
ocutox
PHARMACODYNAMICS ASSESSMENT
- Our Services
- Quantitative drug uptake, penetration, delivery and half life time studies in vivo in vitreous and retina.
- Electron Microscope
- Bioanalytical testing services
- Clinical trials
- Consulting
- Drug pigment interaction assessment
- Early pharmacokinetics
- Early testing
- Formulation
- Models
- Disease models
- Photoreceptor toxicity assessment
- preclinical-development
- Retinal Pigment Epithelium (RPE) toxicity assessment
- Routes of Drug Delivery
- Toxicity studies
- Ocular mode of action
- Knowledge
- Methods
- About
- Contact
- Our Services
- Quantitative drug uptake, penetration, delivery and half life time studies in vivo in vitreous and retina.
- Electron Microscope
- Bioanalytical testing services
- Clinical trials
- Consulting
- Drug pigment interaction assessment
- Early pharmacokinetics
- Early testing
- Formulation
- Models
- Disease models
- Photoreceptor toxicity assessment
- preclinical-development
- Retinal Pigment Epithelium (RPE) toxicity assessment
- Routes of Drug Delivery
- Toxicity studies
- Ocular mode of action
- Knowledge
- Methods
- About
- Contact
Future therapy options in age-related macular degeneration
You are here:
- Home
- Teaching and research videos
- Future therapy options in age-related…
